GVT
PFE icon

Genesee Valley Trust’s Pfizer PFE Stock Holding History

Genesee Valley Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.83M Sell
53,263
-500
-0.9% -$17.2K 0.75% 27
2017
Q4 		$1.85M Sell
53,763
-8,366
-13% -$285K 0.77% 23
2017
Q3 		$2.1M Buy
62,129
+7,732
+14% +$249K 0.86% 20
2017
Q2 		$1.73M Sell
54,397
-5,522
-9% -$174K 0.74% 26
2017
Q1 		$1.94K Buy
59,919
+8,871
+17% +$280K 1.33% 15
2016
Q4 		$1.57K Buy
51,048
+2,163
+4% +$66K 1.11% 21
2016
Q3 		$1.57M Sell
48,885
-4,440
-8% -$148K 0.96% 21
2016
Q2 		$1.78M Buy
53,325
+670
+1% +$21.4K 1.16% 17
2016
Q1 		$1.48M Sell
52,655
-632
-1% -$18.1K 1% 19
2015
Q4 		$1.63M Sell
53,287
-421
-0.8% -$13.2K 1.07% 18
2015
Q3 		$1.6M Sell
53,708
-386
-0.7% -$12.4K 1.06% 18
2015
Q2 		$1.72M Sell
54,094
-1,232
-2% -$40.2K 1.11% 13
2015
Q1 		$1.83M Sell
55,326
-230
-0.4% -$7.31K 1.13% 13
2014
Q4 		$1.64M Sell
55,556
-4,946
-8% -$142K 1.05% 17
2014
Q3 		$1.7M Buy
60,502
+1,982
+3% +$55.6K 1.06% 16
2014
Q2 		$1.65M Buy
58,520
+10,193
+21% +$291K 0.99% 17
2014
Q1 		$1.47M Buy
48,327
+1,034
+2% +$30.8K 0.93% 19
2013
Q4 		$1.37M Sell
47,293
-2,731
-5% -$79.5K 0.91% 16
2013
Q3 		$1.36M Sell
50,024
-2,066
-4% -$56.2K 1.01% 11
2013
Q2 		$1.38M Buy
+52,090
New +$1.44M 1.09% 11

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Genesee Valley Trust's PFE Position: Q1 2018 in Review

Genesee Valley Trust reduced its Pfizer (PFE) stake by 0.93% in Q1 2018, selling an estimated $17.2K and leaving 53,263 shares worth $1.83M. The position accounts for 0.75% of the portfolio, ranked #27.

Genesee Valley Trust first reported a position in PFE in Q2 2013 and has held it in 20 quarters since. The position peaked at $2.1M in Q3 2017. 2,229 funds tracked by Wall St. Rank hold PFE as of Q1 2018.

  • Genesee Valley Trust held 53,263 shares of Pfizer worth $1.83M as of Q1 2018.
  • Genesee Valley Trust sold 500 Pfizer shares in Q1 2018, an estimated $17.2K.
  • Pfizer made up 0.75% of Genesee Valley Trust's portfolio in Q1 2018, its #27 holding.
  • Genesee Valley Trust first reported a position in Pfizer in Q2 2013 and has held it in 20 quarters since.
  • Genesee Valley Trust's Pfizer position peaked at $2.1M in Q3 2017.
  • 2,229 funds tracked by Wall St. Rank held Pfizer as of Q1 2018.

Based on Genesee Valley Trust's 13F filing for Q1 2018, filed 3 Apr 2018.